Three-phase treatment offers patients with HSV infections an alternative to perpetual antiviral management ROATAN, BAY ...
In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...
ABI-1179 demonstrated a favorable safety profile with all treatment-emergent adverse events being mild and not related to the study treatment. The investigational drug ABI-1179 exceeded targeted ...
Lysine supplements are considered safe under most circumstances. Patients with severe renal or hepatic disease should avoid increased lysine intake due to the potential for interstitial damage in both ...
In a nested randomized controlled trial (RCT) published in eClinicalMedicine, researchers examined the effect of Bacillus Calmette-Guérin (BCG) vaccination on attenuating herpes labialis (cold sore) ...
Herpes simplex labialis (HSL) is a common disease caused most often by herpes simplex virus type 1 (HSV-1). Primary infection is usually acquired during childhood or adolescence through direct mucosal ...
Genital herpes infections are very common. There are 42 million new infections each year — that averages out to one new person infected each second. While treatments can help with symptoms, there's no ...
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released today. At least 1 person ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results